Atıf Formatları
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. Kaya And Y. Yılmaz, "Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease," THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM , vol.13, pp.1-13, 2022

Kaya, E. And Yılmaz, Y. 2022. Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM , vol.13 , 1-13.

Kaya, E., & Yılmaz, Y., (2022). Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM , vol.13, 1-13.

Kaya, Eda, And YUSUF YILMAZ. "Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease," THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM , vol.13, 1-13, 2022

Kaya, Eda And Yılmaz, YUSUF. "Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease." THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM , vol.13, pp.1-13, 2022

Kaya, E. And Yılmaz, Y. (2022) . "Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease." THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM , vol.13, pp.1-13.

@article{article, author={Eda Kaya And author={YUSUF YILMAZ}, title={Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease}, journal={THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM}, year=2022, pages={1-13} }